TTi Health Research & Economics

Headquartered in Maryland, TTi serves a diverse clientele, focusing on medical device companies, and including all stakeholders in the health space who have a vested interest in improving patient outcomes, population health, and access to care. We provide the full range of health economics and observational research activities needed to influence health care providers, payers and the public. Utilizing veteran health economists, epidemiologists, market access experts, observational study coordinators, biostatisticians, and medical writers, TTi is the ideal partner to develop and communicate your product's value to a diverse and evolving marketplace. The breadth of our experience across the health care and public health continuum – from patient-level care to the policy, payment, and reimbursement environment – make us uniquely positioned to help you meet your goals.

湖南薇美时光生物科技有限公司

Asbestos and Dust Diseases Research Institute (ADDRI)

Every year, 4,000 Australians lose their lives to dust diseases. As long as mesothelioma, silicosis and asbestos-related diseases threaten public health, we will be relentless in our mission to improve patient outcomes and leave a positive impact on people's lives. Our research institute may be small, but with some of the best research minds in the country and global health leaders behind us, our ambition is large. Our passion and agility are backed by our status as a WHO Collaborating Centre for the Elimination of Asbestos Related Diseases. In the lab, we discover improved prevention methods, diagnosis, and treatment. Our pioneering molecular and biological techniques are scrutinised on blood and tissue specimens stored in the ADRI Biobank. Committed to making a genuine difference, we convert promising therapeutic approaches into clinical practice, provide patient support, and drive advocacy and community awareness. People are the heart of what we do and we will not rest until we find a cure for mesothelioma and address dust and asbestos-related diseases head on.

BioNeutra North America, Inc.

BioNeutra North America (TSX: BGA.V) is a supplier of high quality prebiotic, dietary-fiber and low-caloric sweetener products, including VitaFiber™IMO (www.VitaFiberIMO.com). Founded in 2003, BioNeutra is seeking to become the premier North American supplier of high quality prebiotic and fiber ingredients and products. We are dedicated to addressing the needs of our customers and consumers in both mainstream and functional food markets. Our product line provides ingredients for various food systems, contributing to advanced human nutrition and wellness in functional and healthy foods. Our goal is to move science-based processes into the commercial product marketplace. From our head office and manufacturing base in Edmonton, Alberta, Canada, BioNeutra focuses on providing consistent, quality ingredients for formulators and manufacturers. With patented processes and product knowledge, we are able to leverage the manufacturing technology platform to discover, develop, manufacture, and market novel functional ingredients for food processors and food product formulators. The key product benefits include dietary fiber, prebiotic function, and low caloric nutritive sweetener.

Connect :-: Ways